Literature DB >> 3124587

MR imaging in multiple sclerosis: comparison with clinical, CSF, and visual evoked potential findings.

D Uhlenbrock1, D Seidel, W Gehlen, H K Beyer, J Haan, E Dickmann, T Zeit, E Herbe.   

Abstract

MR examinations of 136 patients with multiple sclerosis (MS) were evaluated to correlate the results with clinical, CSF, and visual evoked potential (VEP) findings. In addition, 22 of the 136 patients were studied several times during a 5-month follow-up period. It was demonstrated that MR is superior to CSF and VEP findings in establishing cerebral alterations in MS. A relationship between the results of CSF and VEP examinations and the MR results could not be detected. Negative CSF and VEP results corresponded to positive MR imaging and vice versa. In our series, five negative MR results were obtained in patients with clinically proved MS. The extent of alterations shown up by MR corresponds to the duration of the disease; in particular, more confluent abnormalities in the periventricular region were found in patients with long-standing disease. More plaques were found in patients with a primary relapsing/remitting course of the disease than with the primary chronic progressive form. The clinical course and the grade of disability did not correspond to differences in MR imaging. Follow-up demonstrated that most lesions remain unchanged (72-79%); increases and decreases in the size of the plaques seem to depend on the clinical course. These results suggest that MR is the most sensitive technique for establishing the diagnosis of MS.

Entities:  

Mesh:

Year:  1988        PMID: 3124587      PMCID: PMC8331543     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  10 in total

Review 1.  Magnetic resonance imaging--2: Clinical uses.

Authors:  P Armstrong; S F Keevil
Journal:  BMJ       Date:  1991-07-13

2.  Neuropsychological assessment in multiple sclerosis: a follow-up study with magnetic resonance imaging.

Authors:  C Mariani; E Farina; S F Cappa; G P Anzola; L Faglia; L Bevilacqua; R Capra; F Mattioli; L A Vignolo
Journal:  J Neurol       Date:  1991-10       Impact factor: 4.849

3.  Neuropsychological assessment in patients with relapsing-remitting multiple sclerosis and mild functional impairment: correlation with magnetic resonance imaging.

Authors:  G P Anzola; L Bevilacqua; S F Cappa; R Capra; L Faglia; E Farina; G Frisoni; C Mariani; M P Pasolini; L A Vignolo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-02       Impact factor: 10.154

4.  One-year MR imaging follow-up of patients with multiple sclerosis under cortisone therapy.

Authors:  D Uhlenbrock; E Herbe; D Seidel; W Gehlen
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

5.  Role of saccadic analysis in the diagnosis of multiple sclerosis in the era of magnetic resonance imaging.

Authors:  G Tedeschi; S Allocca; A Di Costanzo; A Diano; V Bonavita
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-08       Impact factor: 10.154

6.  The callosal-septal interface lesion in multiple sclerosis: effect of sequence and imaging plane.

Authors:  A Jackson; J B Fitzgerald; J E Gillespie
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

7.  Asymptomatic cerebral involvement in Sjögren's syndrome: MRI findings of 15 cases.

Authors:  L Pierot; C Sauve; J M Leger; N Martin; A C Koeger; B Wechsler; J Chiras
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

8.  Atypical demyelinating lesions in patients with multiple sclerosis.

Authors:  Z Yetkin; V M Haughton
Journal:  Neuroradiology       Date:  1995-05       Impact factor: 2.804

Review 9.  The value of T1-weighted images in the differentiation between MS, white matter lesions, and subcortical arteriosclerotic encephalopathy (SAE).

Authors:  D Uhlenbrock; S Sehlen
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

10.  Database for serial magnetic resonance imaging in multiple sclerosis.

Authors:  F Barkhof; A J Thompson; L Kappos; J J Nauta; T Yousri; I Berry; G Scotti; B Appel; P S Tofts; D H Miller
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.